Daniel R. Hart
2023
Compensation breakdown
| Non-Equity Incentive Plan | $225,400 |
|---|---|
| Salary | $442,692 |
| Stock Awards | $1,217,152 |
| Other | $51,654 |
| Total | $1,936,898 |
Hart received $1.2M in stock awards, accounting for 63% of the total pay in 2023.
Hart also received $225.4K in non-equity incentive plan, $442.7K in salary and $51.7K in other compensation.
Rankings
In 2023, Daniel R. Hart's compensation ranked 506th out of 2,242 executives tracked by ExecPay. In other words, Hart earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 506 out of 2,242 | 77th |
Division Manufacturing | 283 out of 1,220 | 77th |
Major group Chemicals And Allied Products | 195 out of 687 | 72nd |
Industry group Drugs | 193 out of 658 | 71st |
Industry Pharmaceutical Preparations | 123 out of 472 | 74th |
Pay ratio
| Daniel R. Hart's Pay | $1,936,898 |
|---|---|
| Median Employee's Pay | $104,595 |
| Pay Ratio | 19to 1 |
In 2023, the annual total compensation of Daniel R. Hart was $1,936,898.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,595.
The ratio of Daniel R. Hart's pay to the pay of median employee was therefore 19 to one.
Hart's colleagues
We found four more compensation records of executives who worked with Daniel R. Hart at Peregrine Pharmaceuticals in 2023.
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019